Epoetin

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3163 publications

Roxadustat in the Treatment of Pure Red Cell Aplasia Associated With Anti-EPO Antibodies.

Roxadustat in the Treatment of Pure Red Cell Aplasia Associated With Anti-EPO Antibodies.

Journal: Kidney medicine
Published: May 28, 2026

Biosimilar adoption and provider performance in Medicare value-based payment models.

Biosimilar adoption and provider performance in Medicare value-based payment models.

Journal: The American journal of managed care
Published: May 26, 2026

Pharmacological treatments for Friedreich ataxia.

Pharmacological treatments for Friedreich ataxia.

Journal: The Cochrane database of systematic reviews
Published: May 12, 2026

Comparison of hemoglobin variability between short- and intermediate-acting erythropoiesis-stimulating agents: a retrospective cohort study.

Comparison of hemoglobin variability between short- and intermediate-acting erythropoiesis-stimulating agents: a retrospective cohort study.

Journal: Journal of Yeungnam medical science
Published: April 24, 2026

RETRACTION: Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury.

RETRACTION: Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury.

Journal: BioMed research international
Published: April 03, 2026

Anemia Management in a Jehovah's Witness Patient With Hip Fracture.

Anemia Management in a Jehovah's Witness Patient With Hip Fracture.

Journal: Cureus
Published: March 31, 2026

Efficacy, safety, and immunogenicity of UB-851 versus Eprex® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trial: Erratum.

Efficacy, safety, and immunogenicity of UB-851 versus Eprex® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trial: Erratum.

Journal: Journal of the Chinese Medical Association : JCMA
Published: March 20, 2026

After Eprex® discontinuation: Multicenter evidence for a biosimilar erythropoietin and health system resilience in Taiwan.

After Eprex® discontinuation: Multicenter evidence for a biosimilar erythropoietin and health system resilience in Taiwan.

Journal: Journal of the Chinese Medical Association : JCMA
Published: March 04, 2026

Complement-Mediated Hemolytic Anemia Triggered by Adenovirus Infection in a Pediatric Patient.

Complement-Mediated Hemolytic Anemia Triggered by Adenovirus Infection in a Pediatric Patient.

Journal: Cureus
Published: February 24, 2026

Copper Replacement: A Life-Saving Treatment.

Copper Replacement: A Life-Saving Treatment.

Journal: Cureus
Published: February 14, 2026

Chemotherapy-Free Achievement of Minimal Residual Disease in a Jehovah's Witness Patient With Ph-Negative B-ALL.

Chemotherapy-Free Achievement of Minimal Residual Disease in a Jehovah's Witness Patient With Ph-Negative B-ALL.

Journal: The American journal of case reports
Published: January 31, 2026

Use of Epoetin Alfa for Anemia of Chronic Disease in a Jehovah's Witness Teenager With Disseminated Coccidioidomycosis: A Case Report.

Use of Epoetin Alfa for Anemia of Chronic Disease in a Jehovah's Witness Teenager With Disseminated Coccidioidomycosis: A Case Report.

Journal: Cureus
Published: January 22, 2026
Showing 1-12 of 3,163

Last Updated: 06/30/2026